Morgan Stanley’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.29M | Buy |
315,731
+33,304
| +12% | +$769K | ﹤0.01% | 3740 |
|
|
2025
Q1 | $7.63M | Buy |
282,427
+64,596
| +30% | +$1.74M | ﹤0.01% | 3572 |
|
|
2024
Q4 | $11.7M | Buy |
217,831
+77,367
| +55% | +$4.14M | ﹤0.01% | 3282 |
|
|
2024
Q3 | $6.38M | Buy |
140,464
+58,666
| +72% | +$2.67M | ﹤0.01% | 3778 |
|
|
2024
Q2 | $3.43M | Sell |
81,798
-39,433
| -33% | -$1.65M | ﹤0.01% | 4187 |
|
|
2024
Q1 | $4.56M | Sell |
121,231
-13,665
| -10% | -$514K | ﹤0.01% | 3980 |
|
|
2023
Q4 | $1.45M | Buy |
134,896
+114,440
| +559% | +$1.23M | ﹤0.01% | 5122 |
|
|
2023
Q3 | $206K | Buy |
20,456
+1,975
| +11% | +$19.9K | ﹤0.01% | 5563 |
|
|
2023
Q2 | $219K | Sell |
18,481
-15,023
| -45% | -$178K | ﹤0.01% | 5612 |
|
|
2023
Q1 | $405K | Buy |
33,504
+16,020
| +92% | +$194K | ﹤0.01% | 5371 |
|
|
2022
Q4 | $230K | Sell |
17,484
-123,996
| -88% | -$1.63M | ﹤0.01% | 5607 |
|
|
2022
Q3 | $1.92M | Buy |
141,480
+113,747
| +410% | +$1.54M | ﹤0.01% | 4461 |
|
|
2022
Q2 | $337K | Sell |
27,733
-10
| -0% | -$122 | ﹤0.01% | 5621 |
|
|
2022
Q1 | $398K | Buy |
27,743
+13,264
| +92% | +$190K | ﹤0.01% | 5534 |
|
|
2021
Q4 | $285K | Buy |
14,479
+7,777
| +116% | +$153K | ﹤0.01% | 5874 |
|
|
2021
Q3 | $145K | Buy |
6,702
+6,602
| +6,602% | +$143K | ﹤0.01% | 6170 |
|
|
2021
Q2 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 7526 |
|